Bicycle Therapeutics Ltd
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | 7.0 | 21.3 | 12.2 | 28.9 | 33.0 | 31.4 | 36.5 | 59.7 | 64.8 | 88.5 | 149.9 | 94.5 | 30.5 | 45.9 | 60.8 | 41.2 | 34.2 | 32.0 | 28.5 | 25.5 | 26.5 | 42.3 | 27.4 | 22.9 | 25.1 | 18.8 | 6.8 | 5.0 | 4.8 | |
| – | – | – | – | – | – | 0.7 | 2.1 | 1.8 | 3.0 | 4.0 | 3.4 | 4.0 | 4.7 | 5.1 | 6.1 | 5.1 | 3.9 | 1.6 | 2.4 | 3.2 | 2.6 | 3.5 | 1.9 | 2.1 | 3.0 | 1.2 | 1.9 | 1.2 | 0.8 | 0.7 | 0.9 | 0.8 | 0.6 | 0.6 | |
| – | – | – | – | – | – | -3.2 | 11.4 | 5.6 | 16.1 | 21.8 | 20.0 | 24.9 | 44.7 | 49.9 | 69.0 | 115.2 | 67.3 | 9.7 | 24.1 | 39.7 | 24.5 | 20.6 | 10.4 | 10.3 | 15.3 | 3.2 | 18.3 | 2.6 | -7.7 | -12.0 | -3.9 | -1.8 | -3.7 | – | |
| – | – | – | – | – | – | -37.6% | -16.7% | -18.0% | -1.6% | -3.0% | -2.0% | -5.1% | -8.2% | -7.4% | -2.1% | -0.9% | -2.6% | -10.7% | -12.0% | -11.7% | -18.9% | -7.1% | -6.0% | -8.3% | -8.1% | -15.7% | -13.1% | -17.2% | -31.0% | -43.4% | -45.4% | -50.7% | -71.4% | -70.1% | |
| Margins | |||||||||||||||||||||||||||||||||||
| – | – | – | -172.8% | -190.9% | -117.8% | -136.0% | -165.1% | -85.1% | -216.4% | -138.5% | -22.0% | -71.6% | 9.1% | 10.9% | 14.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -23.7% | -188.4% | -518.1% | -1,093.0% | -550.6% | -76.8% | -11.9% | 100.0% | |
| – | – | – | -300.3% | -304.7% | -206.8% | -238.2% | -303.6% | -190.6% | -405.4% | -456.6% | -335.5% | -500.1% | -509.0% | -541.0% | -549.1% | -561.0% | -559.9% | -532.4% | -680.9% | -806.6% | -845.7% | -652.3% | -676.3% | -704.1% | -432.2% | -463.4% | -532.4% | -595.0% | -965.6% | -1,495.3% | -1,023.4% | -340.3% | -381.8% | -343.7% | |
| – | – | – | -312.3% | -306.1% | -241.0% | -293.7% | -342.9% | -221.8% | -414.6% | -434.3% | -321.3% | -491.0% | -504.8% | -546.6% | -562.4% | -571.2% | -568.7% | -533.0% | -669.7% | -779.3% | -801.5% | -621.7% | -650.6% | -669.7% | -404.1% | -417.9% | -450.6% | -479.2% | -790.1% | -1,257.0% | -884.5% | -301.7% | -345.0% | -311.1% | |
| – | – | – | -300.6% | -382.1% | -236.6% | -262.3% | -356.3% | -219.2% | -46.5% | -99.5% | -63.2% | -184.5% | -489.3% | -479.1% | -188.9% | -142.3% | -241.4% | -324.9% | -549.3% | -711.6% | -777.8% | -241.1% | -193.2% | -235.6% | -206.4% | -416.5% | -551.7% | -470.6% | -709.4% | -1,092.4% | -854.7% | -344.0% | -360.7% | -335.9% | |
| Returns | |||||||||||||||||||||||||||||||||||
| – | – | – | -73.5% | – | -45.4% | -29.7% | -34.5% | -32.8% | -43.3% | -52.6% | -34.7% | -53.4% | -39.3% | -43.4% | -38.8% | -19.3% | -23.7% | -28.0% | -34.8% | -41.6% | -51.1% | -63.6% | -38.8% | -48.7% | -47.2% | -18.9% | -20.0% | -21.3% | -27.5% | -36.2% | -40.5% | -35.9% | -39.5% | -37.3% | |
| – | – | – | -33.7% | -26.8% | -33.2% | -24.6% | -28.3% | -27.8% | -27.4% | -31.5% | -22.3% | -31.7% | -25.0% | -27.3% | -23.5% | -13.9% | -17.0% | -19.6% | -24.2% | -27.5% | -29.0% | -30.8% | -25.3% | -30.3% | -30.7% | -15.6% | -16.7% | -17.7% | -23.0% | -29.1% | -32.8% | -30.5% | -33.6% | -31.4% | |
| Balance Sheet & Debt | |||||||||||||||||||||||||||||||||||
| -68 | 68 | – | – | -56 | -57 | -108 | -95 | -91 | -109 | -96 | -135 | -121 | -166 | -168 | -229 | -406 | -374 | -340 | -328 | -306 | -259 | -305 | -537 | -491 | -421 | -925 | -885 | -874 | -787 | -716 | -644 | -625 | -558 | – | |
| 66.6% | – | – | 45.9% | -85.5% | 73.2% | 82.8% | 82.1% | 84.6% | 63.3% | 59.9% | 64.4% | 59.2% | 63.5% | 62.8% | 60.7% | 72.2% | 71.9% | 69.9% | 69.4% | 65.9% | 56.7% | 48.5% | 65.1% | 62.3% | 65.1% | 82.6% | 83.4% | 82.9% | 83.8% | 80.4% | 81.0% | 85.0% | 85.0% | 84.1% | |
| 0.0 | 0.0 | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | |
| Per Share | |||||||||||||||||||||||||||||||||||
| – | – | – | -1.58 | -1.64 | -1.46 | -4.25 | -1.83 | -1.71 | -1.97 | -2.06 | -1.96 | -2.42 | -2.53 | -2.56 | -2.64 | -2.32 | -2.64 | -2.94 | -3.40 | -3.79 | -4.14 | -4.64 | -4.08 | -4.26 | -3.95 | -3.18 | -2.41 | -2.45 | -2.94 | -3.50 | -3.62 | -3.16 | -3.14 | -2.73 | |
| – | – | – | 0.51 | 0.54 | 0.61 | 1.45 | 0.53 | 0.77 | 0.47 | 0.48 | 0.61 | 0.49 | 0.50 | 0.47 | 0.47 | 0.41 | 0.46 | 0.55 | 0.51 | 0.49 | 0.52 | 0.75 | 0.63 | 0.64 | 0.98 | 0.76 | 0.53 | 0.51 | 0.37 | 0.28 | 0.41 | 1.05 | 0.91 | 0.88 | |
| 3.18 | 3.71 | – | 2.15 | -5.25 | 3.22 | 14.33 | 5.33 | 5.20 | 4.55 | 3.93 | 5.64 | 4.53 | 6.43 | 5.91 | 6.82 | 12.03 | 11.16 | 10.50 | 9.75 | 9.11 | 8.10 | 7.29 | 10.51 | 8.74 | 8.37 | 16.81 | 12.05 | 11.49 | 10.70 | 9.66 | 8.92 | 8.79 | 7.95 | 7.31 | |
| – | – | – | -1.52 | -2.05 | -1.43 | -3.80 | -1.91 | -1.69 | -0.22 | -0.47 | -0.38 | -0.91 | -2.45 | -2.25 | -0.89 | -0.58 | -1.12 | -1.79 | -2.79 | -3.46 | -4.02 | -1.80 | -1.21 | -1.50 | -2.02 | -3.17 | -2.95 | -2.40 | -2.64 | -3.04 | -3.49 | -3.60 | -3.29 | -2.95 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.